Theratechnologies to Present at the Cantor Fitzgerald Global Healthcare Conference 2023
20 Setembro 2023 - 8:00AM
Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX:
TH) (NASDAQ: THTX), a biopharmaceutical company focused on the
development and commercialization of innovative therapies, today
announced that Mr. Paul Lévesque, President and Chief Executive
Officer, will participate in a panel presentation at the Cantor
Fitzgerald Global Healthcare Conference 2023 being held September
26-28 in New York City.
Presentation Details |
|
|
Date: |
Wednesday, September 27,
2023 |
Time: |
8:00 - 8:30 AM EDT in Track
2 |
Location: |
Intercontinental Barclay New
York Hotel |
|
|
Mr. Lévesque and Mr. Philippe Dubuc, Senior Vice President and
Chief Financial Officer, will also be available for 1x1 investor
meetings.
About Theratechnologies
Theratechnologies (TSX: TH) (NASDAQ: THTX) is a
biopharmaceutical company focused on the development and
commercialization of innovative therapies addressing unmet medical
needs. Further information about Theratechnologies is available on
the Company's website at www.theratech.com, on SEDAR at
www.sedarplus.ca and on EDGAR at www.sec.gov. Follow
Theratechnologies on Linkedin and Twitter.
Contacts:
Investor Inquiries:Philippe DubucSenior Vice President and Chief
Financial Officerpdubuc@theratech.com 438-315-6608
Theratechnologies (NASDAQ:THTX)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Theratechnologies (NASDAQ:THTX)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024